Vanda Pharmaceuticals (VNDA) Inventory Average (2012 - 2026)

Vanda Pharmaceuticals has reported Inventory Average for 15 years, with the latest figure at $6.4 million in Q1 2026.

• Quarterly Inventory Average rose 11.22% year-over-year to $6.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.4 million (up 11.22% YoY) and the FY2025 annual result came in at $10.3 million, up 88.9% from the prior year.
• Inventory Average fell to $6.4 million in Q1 2026 per VNDA's latest filing, from $10.5 million in the prior quarter.
• Over five years, Inventory Average peaked at $11.3 million in Q4 2022 and troughed at $1.4 million in Q2 2022.
• A 5-year average of $6.5 million and a median of $6.1 million in 2025 frame the typical range for Inventory Average.
• The sharpest annual moves came in 2023 and 2024: Inventory Average surged 649.07% in 2023, then tumbled 87.1% in 2024.
• Over 5 years, Inventory Average stood at $11.3 million in 2022, then slumped by 48.55% to $5.8 million in 2023, then surged by 64.23% to $9.5 million in 2024, then rose by 10.54% to $10.5 million in 2025, then slumped by 39.6% to $6.4 million in 2026.
• According to Business Quant data, Inventory Average over the past three periods registered $6.4 million, $10.5 million, and $6.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.